Cargando…

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease

Alzheimer's disease (AD), a progressive neurodegenerative disorder, is a leading global health concern for individuals and society. However, the potential mechanisms underlying the pathogenesis of AD have not yet been elucidated. Currently, the most widely acknowledged hypothesis is amyloid cas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Weiwei, Jin, Haiqiang, Huang, Yining
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Aging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796309/ https://www.ncbi.nlm.nih.gov/pubmed/33404051 http://dx.doi.org/10.1042/CS20200844

Ejemplares similares

Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
por: Eysert, Fanny, et al.
Publicado: (2020)

The contribution of mitochondria-associated endoplasmic reticulum membranes (MAMs) dysfunction in Alzheimer’s disease and the potential countermeasure
por: Li, Zehui, et al.
Publicado: (2023)

Mitochondria-associated membranes (MAMs) and pathologies
por: Pinton, Paolo
Publicado: (2018)

Mitochondria-associated membranes (MAMs) and inflammation
por: Missiroli, Sonia, et al.
Publicado: (2018)

Mitochondria-associated endoplasmic reticulum membranes (MAMs): Possible therapeutic targets in heart failure
por: Zhang, Yu, et al.
Publicado: (2023)

Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
por: Annunziata, Ida, et al.
Publicado: (2018)

Calcium signaling around Mitochondria Associated Membranes (MAMs)
por: Patergnani, Simone, et al.
Publicado: (2011)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2021)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

Structural and Functional Alterations in Mitochondria-Associated Membranes (MAMs) and in Mitochondria Activate Stress Response Mechanisms in an In Vitro Model of Alzheimer’s Disease
por: Fernandes, Tânia, et al.
Publicado: (2021)

Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Prospective Roles in Kidney Disease
por: Gao, Peng, et al.
Publicado: (2020)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Structure and Function of Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Role in Cardiovascular Diseases
por: Luan, Yi, et al.
Publicado: (2021)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Editorial: Recent advances in mitochondria-associated endoplasmic reticulum membranes (MAMs) in heart-related diseases
por: Yang, Yang, et al.
Publicado: (2023)

Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential
por: Chen, Yanting, et al.
Publicado: (2023)

Mitochondria-Associated Membranes (MAMs) are involved in Bax mitochondrial localization and cytochrome c release
por: Légiot, Alexandre, et al.
Publicado: (2019)

Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
por: Atlante, Anna, et al.
Publicado: (2022)

A Perspective on the Link between Mitochondria-Associated Membranes (MAMs) and Lipid Droplets Metabolism in Neurodegenerative Diseases
por: Fernandes, Tânia, et al.
Publicado: (2023)

Broadening horizons: the contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease
por: Liu, Yong, et al.
Publicado: (2023)

Role of Mitochondria in Retinal Pigment Epithelial Aging and Degeneration
por: Tong, Yao, et al.
Publicado: (2022)

There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
por: Paillusson, Sebastien, et al.
Publicado: (2016)

Connection Lost, MAM: Errors in ER–Mitochondria Connections in Neurodegenerative Diseases
por: Johri, Ashu, et al.
Publicado: (2021)

The untapped potential of targeting NRF2 in neurodegenerative disease
por: Chen, Wei-Tai, et al.
Publicado: (2023)

Corrigendum: The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis
por: Majerníková, Nad'a, et al.
Publicado: (2022)

Small-molecule drugs development for Alzheimer's disease
por: Yao, Weiwei, et al.
Publicado: (2022)

Targeting Impaired Nutrient Sensing via the Glycogen Synthase Kinase-3 Pathway With Therapeutic Compounds to Prevent or Treat Dementia: A Systematic Review
por: Matysek, Adrian, et al.
Publicado: (2022)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease
por: Nizari, Shereen, et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Recent Advances on Drug Development and Emerging Therapeutic Agents Through Targeting Cellular Homeostasis for Ageing and Cardiovascular Disease
por: Azam, Tayyiba, et al.
Publicado: (2022)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

Klotho and calciprotein particles as therapeutic targets against accelerated ageing
por: Kuro-o, Makoto
Publicado: (2021)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Impact prediction of translocation of the mitochondrial outer membrane 70 as biomarker in Alzheimer's disease
por: Cao, Xi, et al.
Publicado: (2022)

Effects of DISC1 on Alzheimer’s disease cell models assessed by iTRAQ proteomics analysis
por: Lu, Jiajie, et al.
Publicado: (2022)

Regulation of Mitochondria-Associated Membranes (MAMs) by NO/sGC/PKG Participates in the Control of Hepatic Insulin Response
por: Bassot, Arthur, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lbuvcnepaikpfkln9ccc6eckpp